Toronto Dominion Bank’s Exagen XGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-20,029
Closed -$122K 2441
2025
Q4
$122K Hold
20,029
﹤0.01% 1536
2025
Q3
$220K Sell
20,029
-831,260
-98% -$7.36M ﹤0.01% 1388
2025
Q2
$5.94M Sell
851,289
-40,077
-4% -$244K 0.01% 711
2025
Q1
$3.2M Hold
891,366
0.01% 804
2024
Q4
$3.65M Buy
+891,366
New +$3.21M 0.01% 783

Other funds holding XGN

Toronto Dominion Bank's XGN Position: Q1 2026 in Review

Toronto Dominion Bank sold out of Exagen (XGN) in Q1 2026, closing a stake of 20,029 shares — an estimated $122K sold.

Toronto Dominion Bank first reported a position in XGN in Q4 2024 and held it in 5 quarters. The position peaked at $5.94M in Q2 2025. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • Toronto Dominion Bank reported no remaining Exagen position as of Q1 2026 after selling out during the quarter.
  • Toronto Dominion Bank sold 20,029 Exagen shares in Q1 2026, an estimated $122K.
  • Toronto Dominion Bank first reported a position in Exagen in Q4 2024 and held it in 5 quarters.
  • Toronto Dominion Bank's Exagen position peaked at $5.94M in Q2 2025.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.